- Home
- Pathology Industry
- Antigen Market and Forecasts, May 2013
Industries
- Pathology (120)
- Drug and Medication (110)
- Biopharmaceutical (75)
- Biotechnology (61)
- Biological Therapy (48)
-
- Diagnostics (24)
- Agriculture (20)
- Energy & Environment (16)
- In Vitro Diagnostic (15)
- Blood Supply, Tissue Banking and Transplantation (14)
- Genomics (13)
- Veterinary Healthcare (12)
- Fish and Seafood (11)
- Machine Tool and Equipment (11)
- Pharmaceutical (8)
- Drug Discovery and Development (6)
- Healthcare (6)
- Meat and Poultry (6)
- Chemical and Material (5)
- Dairy Products and Egg (5)
Top countries
Publication dates
All regions
-
- Austria (2)
- Belgium (3)
- Bulgaria (1)
- Croatia (1)
- Cyprus (1)
- Czech Republic (2)
- Denmark (4)
- Finland (3)
- France (8)
- Germany (15)
- Hungary (1)
- Iceland (2)
- Ireland (9)
- Italy (5)
- Lithuania (1)
- Luxembourg (2)
- Macedonia (1)
- Netherlands (6)
- Norway (6)
- Poland (1)
- Romania (1)
- Russian Federation (6)
- Serbia and Montenegro (3)
- Spain (8)
- Sweden (4)
- Switzerland (6)
- Ukraine (1)
- United Kingdom (16)
-
- Australia (30)
- Austria (2)
- Belgium (3)
- Canada (33)
- Chile (3)
- Czech Republic (2)
- Denmark (4)
- Finland (3)
- France (8)
- Germany (15)
- Hungary (1)
- Iceland (2)
- Ireland (9)
- Israel (3)
- Italy (5)
- Japan (18)
- Luxembourg (2)
- Mexico (2)
- Netherlands (6)
- New Zealand (6)
- Norway (6)
- Poland (1)
- South Korea (6)
- Spain (8)
- Sweden (4)
- Switzerland (6)
- United Kingdom (16)
- United States (255)
data types
- All
- Company Data (746)
- Industry Data
- Country Data (131)
Antigen Market and Forecasts, May 2013
You might be interested in: vaccine, antibody, protein, more »
industry reports
The Egyptian Antigen Market : Production and Trade Statistics (antigen, antibody)
- Industry report
- March 2011
- 9 pages
... Count (wbcs) and hematocrit value ( before and after separation ). The results showed that the injection of srbcs antigen significantly increased the antibody (ab) titers (10.429 Vs 9.613), The rbcs ...
- Industries: Biopharmaceutical
- Countries: Egypt
Protein Industry (protein, antigen) in The United States and Brazil
- Industry report
- March 2012
- 9 pages
- by Research Paper
... antigen was chosen because it has been used as a vaccine against peripheral blood mononucleosis, and previous results have shown that it is an effective stimulator of cytokine production in human ...
- Industries: Biopharmaceutical
- Countries: United States, Brazil
Animal Vaccine Market (animal vaccine, antigen, protein) in Australia
- Industry report
- April 2012
- 14 pages
... While it is possible that some metabolic components present in crude leaf extracts have synergistic, adjuvant effects when combined with antigenic proteins to improve the immune response [23 ...
- Industries: Biopharmaceutical
- Countries: Australia
Biopharmaceutical Sector Analysis in The United States
- Industry report
- May 2012
- 53 pages
- by Research Paper
... Production of recombinant proteins in plants therapeutical applications for animals and humans Plantibodies: monoclonal antibodies for passive immune therapy antigens as edible vaccines 18.05.2012 Cell ...
- Industries: Biopharmaceutical
- Countries: United States
Biopharmaceutical Business Brief
- Industry report
- May 2012
- 8 pages
- by Corporation
... In the absence of adjuvant are able to induce a protective immune response, suggesting that some phytochemicals could synergistically affect the immuno- genicity of plant-expressed antigens acting as endogenous ...
- Industries: Biopharmaceutical
Biopharmaceutical in The United States, France and Canada : Innovation and Technology Trends
- Industry report
- September 2011
- 2 pages
... Large volumes of vaccine antigens to the world market. Medicago has reported positive phase ii clinical results for its h5n1 pandemic influenza vlp vaccine and positive u.S. Phase i results for its ...
- Industries: Biopharmaceutical
- Countries: United States, France, Canada
Protein Market in Brazil
- Industry report
- May 2011
- 7 pages
- by Research Paper
... Specific antigens in order to develop vaccines and diagnostic kits against this disease. The objective of this study was to evaluate the influence of culture medium on the production of eif antigen from ...
- Industries: Biopharmaceutical
- Countries: Brazil
Protein Market in Canada
- Industry report
- March 2012
- 5 pages
... The antigen from degradation as it passes through the gastrointestinal tract, while at the same time being capable of delivering an antigen to the mucosal immune system. Plant virus vectors have been designed ...
- Industries: Biopharmaceutical
- Countries: Canada
Vaccine Sector (vaccine, monoclonal antibody) in Canada
- Industry report
- December 2011
- 7 pages
... In the battle against cancer. Plant-derived vaccines can both deliver an antigen to the mucosal immune system in the form of a food product, as well as prevent the antigen from degradation as it passes through ...
- Industries: Biopharmaceutical
- Countries: Canada
Vaccine Market (vaccine, monoclonal antibody) in Canada
- Industry report
- December 2011
- 7 pages
... In the battle against cancer. Plant-derived vaccines can both deliver an antigen to the mucosal immune system in the form of a food product, as well as prevent the antigen from degradation as it passes through ...
- Industries: Biopharmaceutical
- Countries: Canada
» Read our Company Profiles
1 Companies for AntigenMaterials and Methods
United StatesReportlinker.com © Copyright 2013. All rights reserved.
